Global Thyroid Cancer Overdiagnosis in Children and Adolescents Global Thyroid Cancer Overdiagnosis in Children and Adolescents
The incidence of thyroid cancer among children and adolescents around the world mimics the patterns in adults, which are attributed to an"epidemic of overdiagnosis."Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Technique Uses Voice to Evaluate Thyroid Nodules New Technique Uses Voice to Evaluate Thyroid Nodules
An investigational elastography technique for evaluating thyroid nodules uses an ultrasound device held to the throat while an individual vocalises.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Global Demand for Cancer Surgery Expected to Soar Global Demand for Cancer Surgery Expected to Soar
The demand for cancer surgery will soar, along with a demand for surgeons and anesthesists, but perioperative care needs to improve, particularly in lower-income countries.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Even Patients With Cancer in Remission at Risk for Severe COVID Even Patients With Cancer in Remission at Risk for Severe COVID
A new study shows that, like patients with active cancer, even patients with cancer that is in remission are at increased risk for severe COVID-19 complications.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer
These products are often essential for the treatment of pancreatic cancer, but out-of-pocket costs for a 30-day supply on Medicare can reach $1000 or more.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Triplet Shows'Promising' Activity in Unresectable/Metastatic CRC Triplet Shows'Promising' Activity in Unresectable/Metastatic CRC
Combining an EGFR inhibitor with a pair of checkpoint inhibitors can produce'promising'activity in certain patients with colorectal cancer, according to an investigator from a phase 2 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How Much Does Drinking Alcohol Contribute to US Cancer Burden? How Much Does Drinking Alcohol Contribute to US Cancer Burden?
Alcohol consumption accounts for 4.8% of all cancer cases overall, but this rises to 12.1% of female breast cancer, 11% of colorectal cancer, and more than 45% of mouth and throat cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Major Advancement' in Preventing Neutropenia, Says Trialist'Major Advancement' in Preventing Neutropenia, Says Trialist
Growth factors have been the standard of care for preventing chemotherapy-induced neutropenia for decades. Could adding a new agent improve efficacy, and what should be the measure of that efficacy?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Groups Jointly Issue Guidelines for Von Willebrand Disease
MONDAY, Jan. 25, 2021 -- Recommendations are presented for the diagnosis and management of von Willebrand disease (VWD) in two clinical guidelines issued by the American Society of Hematology, International Society on Thrombosis and Haemostasis,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2021 Category: Pharmaceuticals Source Type: news

ColCORONA: Colchicine Reduces Complications in Outpatient COVID-19 ColCORONA: Colchicine Reduces Complications in Outpatient COVID-19
The primary endpoint was not significant in the overall population, but in those with PCR-confirmed COVID, treatment reduced hospitalization, need for ventilation, and death, top-line results show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2021 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

What Causes Lethargy?
Discussion Lethargy is a common word used to describe a person who is drowsy, sluggish, listless and apathetic. Concentration may be difficult and they may have problems doing simple tasks. Many people actual mean fatigue or lassitude or being more tired when they use the word. In medical terms, lethargy is usually used to describe patients who have some type of excessive tiredness and usually have mental status changes with decreased alertness or arousal. Patients and health care providers both usually qualify the term and give more description to better communicate what is implied when using the term. This is true of man...
Source: PediatricEducation.org - January 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

FDA approves nivolumab plus cabozantinib for advanced renal cell carcinoma
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 22, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Tool Predicts Severe Toxicity From Chemo in Breast Cancer Tool Predicts Severe Toxicity From Chemo in Breast Cancer
A new tool for predicting the risk of severe chemotherapy toxicity in older adults with early-stage breast cancer outperforms existing models.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk
A large Swedish study shows those treated with LT3 in combination with LT4 for hypothyroidism have no greater breast cancer risk than individuals taking LT4 alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

NCCN shares new guidance principles for vaccinating people with cancer against COVID-19
(National Comprehensive Cancer Network) The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2021 Category: Cancer & Oncology Source Type: news

Novel Blood Test Detects Precancerous Colorectal Adenomas Novel Blood Test Detects Precancerous Colorectal Adenomas
A novel multiomics blood test was shown to detect advanced colorectal adenomas at comparable or better rates than currently available stool tests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Screenings Rebound After COVID Surge, but Catch-Up Needed Cancer Screenings Rebound After COVID Surge, but Catch-Up Needed
A single-institution study shows that cancer screenings rebounded after the first COVID surge, but an expert stresses the need for catch-up and finding missed diagnoses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 21, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer Screenings Rebound After COVID Surge, but Catch-Up Needed Cancer Screenings Rebound After COVID Surge, but Catch-Up Needed
A single-institution study shows that cancer screenings rebounded after the first COVID surge, but an expert stresses the need for catch-up and finding missed diagnoses.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mental Illness Tied to High Risk of Physical Disease, Death Mental Illness Tied to High Risk of Physical Disease, Death
Mental illness in young individuals is associated with a strikingly high risk of subsequent physical illness, disability, and premature mortality, results of a large longitudinal study show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 21, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

New Standard for Borderline Resectable Pancreatic Cancer New Standard for Borderline Resectable Pancreatic Cancer
Neoadjuvant mFOLFIRINOX was associated with favorable overall survival compared to historical data, but the addition of hypofractionated radiotherapy did not improve outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Standard for Borderline Resectable Pancreatic Cancer New Standard for Borderline Resectable Pancreatic Cancer
Neoadjuvant mFOLFIRINOX was associated with favorable overall survival compared to historical data, but the addition of hypofractionated radiotherapy did not improve outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves First and Only Treatment for AL Amyloidosis FDA Approves First and Only Treatment for AL Amyloidosis
Accelerated approval has been granted to daratumumab in combination with bortezomib, cyclophosphamide, and dexamethasone for treatment of newly diagnosed light chain amyloidosis.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

FDA Approves First and Only Treatment for AL Amyloidosis FDA Approves First and Only Treatment for AL Amyloidosis
Accelerated approval has been granted to daratumumab in combination with bortezomib, cyclophosphamide, and dexamethasone for treatment of newly diagnosed light chain amyloidosis.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival
Adding bemarituzumab to chemotherapy as first-line treatment for advanced gastric and gastroesophageal junction (GEJ) cancers improved survival over chemotherapy alone in the phase 2 FIGHT trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 19, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Many ED Visits May Be Preventable for Patients With NSCLC Many ED Visits May Be Preventable for Patients With NSCLC
The authors of a study in JCO Oncology Practice note that unplanned hospital visits are among the largest drivers of increased spending in advanced cancer care, accounting for 48% of spending.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - January 19, 2021 Category: Emergency Medicine Tags: Hematology-Oncology News Source Type: news

Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival Bemarituzumab FIGHTs Gastric/GEJ Cancers, Improving Survival
Adding bemarituzumab to chemotherapy as first-line treatment for advanced gastric and gastroesophageal junction (GEJ) cancers improved survival over chemotherapy alone in the phase 2 FIGHT trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 19, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Many ED Visits May Be Preventable for Patients With NSCLC Many ED Visits May Be Preventable for Patients With NSCLC
The authors of a study in JCO Oncology Practice note that unplanned hospital visits are among the largest drivers of increased spending in advanced cancer care, accounting for 48% of spending.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer
Women who receive ovarian stimulation for assisted reproductive technology (ART) procedures don't have an increased risk of developing ovarian cancer, according to a new study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer
Women who receive ovarian stimulation for assisted reproductive technology (ART) procedures don't have an increased risk of developing ovarian cancer, according to a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 19, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Osimertinib: A Bright Spot at the End of a Dismal 2020 Osimertinib: A Bright Spot at the End of a Dismal 2020
Approval of the first adjunctive treatment for patients with stage IB to IIIA lung cancer is a harbinger of targeted therapies to come, says Dr Mark Kris.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Cancer Surgery Mortality Down, but Racial Disparities Persist Cancer Surgery Mortality Down, but Racial Disparities Persist
In recent years, deaths after cancer surgery have decreased for all types of cancer except among Black patients undergoing prostate cancer surgery, but racial disparity gaps persist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Top 10 Advances in Thoracic Oncology in 2020 Top 10 Advances in Thoracic Oncology in 2020
Dr Mark Kris details what he considers the 10 most important developments in lung cancer management from 2020.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Cancer Surgery Mortality Down, but Racial Disparities Persist Cancer Surgery Mortality Down, but Racial Disparities Persist
In recent years, deaths after cancer surgery have decreased for all types of cancer except among Black patients undergoing prostate cancer surgery, but racial disparity gaps persist.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 19, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Unexpectedly, Immunotherapy Response Linked to Low TMB in rGMB Unexpectedly, Immunotherapy Response Linked to Low TMB in rGMB
In contrast to what has been seen in other tumor types, recurrent glioblastoma (rGMB) appears to respond better to immunotherapy when tumor mutational burden (TMB) is low.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Better Survival With S-1/Docetaxel in Stage III Gastric Cancer Better Survival With S-1/Docetaxel in Stage III Gastric Cancer
Postoperative adjuvant S-1/docetaxel after D2 gastrectomy significantly improved survival in comparison with S-1 alone for patients with stage III gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 -- (Healthcare Sales & Marketing Network) -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, toda... Biopharmaceuticals, Oncology, Regulatory Tessa Therapeutics, CAR-T therapy, Hodgkin Lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2021 Category: Pharmaceuticals Source Type: news

Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer? Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?
Preliminary data suggest that the diversity of the gut microbiome could potentially predict nivolumab response for patients with gastric cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 15, 2021 (HORSHAM, Pa.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] DARZALEX FASPRO® is the first and only FDA-approved treatment for patients with this blood cell disorder that is associated with the production of an abnormal protein, which leads to th...
Source: Johnson and Johnson - January 16, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Baby Gets Cancer From Mother During Birth: First Report Baby Gets Cancer From Mother During Birth: First Report
For the first time, transmission of cancer via the birth canal has been documented: the mothers had cervical cancer, the infants later developed lung cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Baby Gets Cancer From Mother During Birth: First Report Baby Gets Cancer From Mother During Birth: First Report
For the first time, transmission of cancer via the birth canal has been documented: the mothers had cervical cancer, the infants later developed lung cancer.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - January 15, 2021 Category: Pediatrics Tags: Hematology-Oncology News Source Type: news

Research shows gene therapies can offer cost savings potential of up to $1.8M over five years for patients with certain blood diseases
Arecent analysis by Health Advances looks at two particularly burdensome hematological (or blood) diseases — beta thalassemia andhemophilia A— and finds that potential gene therapies in the pipeline could reduce per patient costs by as much as 41% and 90%, respectively, over five years. Research-based knowledge gained in recent years about the genetic foundation for these diseases has facilitated the pursuit of several promising gene t herapy approaches. (Source: The Catalyst)
Source: The Catalyst - January 15, 2021 Category: Pharmaceuticals Authors: Katie Koziara Tags: Rare Diseases Drug Cost New Era of Medicine The Value Collaborative Source Type: news

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
In an effort to counteract alarming trends in rising hepatitis infections, the HHS has developed and released its Viral Hepatitis National Strategic Plan 2021-2025.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2021 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

FDA approves crizotinib for children and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma
Hematology/Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Quadruple-Negative Breast Cancer: Novel Implications Quadruple-Negative Breast Cancer: Novel Implications
Recent developments in our understanding of quadruple-negative breast cancer could have important implications for therapy development and future research.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Toxoplasma Gondii Infection May Be Tied to Higher Risk of Brain Cancer Toxoplasma Gondii Infection May Be Tied to Higher Risk of Brain Cancer
Data from two prospective studies point to an association between Toxoplasma gondii infection and the risk of glioma in adults, suggesting that reducing exposure could provide an avenue to modify glioma risk, the researchers say.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 14, 2021 Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news

Does Screening for Skin Cancer Result in Melanoma Overdiagnosis? Does Screening for Skin Cancer Result in Melanoma Overdiagnosis?
Screening for skin cancer should stop, as it is contributing to an overdiagnosis of melanoma, say NEJM authors, but the issue is nuanced, retort melanoma experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 14, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news